MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal Transition-Reference-Cited by-同舟云学术

MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal Transition

Published:2021-11-17 Issue:47 Volume:6 Page:31435-31446
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Wei Weitian¹²^ORCID,Wang Liang²,Xu Liwei²,Liang Jinxiao²,Teng Lisong¹

Affiliation:

1. Department of Surgical Oncology, Zhejiang University School of Medicine First Affiliated Hospital, No. 79 Qingchun Road, Shangcheng District, Hangzhou 310009, China

2. Department of Surgical Oncology, Zhejiang Cancer Hospital, No. 1, East Banshan Road, Gongshu District, Hangzhou 310022, China

Funder

Natural Science Foundation of Zhejiang Province

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.1c02945

Reference40 articles.

1. Pancreatic cancer: diagnosis and treatments

2. Anonymous, Cancer Facts & Figures 2017; Cancer Facts & Figures, 2017.

3. Anonymous, Cancer Facts & Figures 2018; Cancer Facts & Figures, 2018.

4. Pancreatic Cancer Registry in Japan

5. Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells;Heliyon;2024-05

2. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches;Environmental Research;2024-01

3. Pancreatic cancer and stem cell;Cancer Stem Cells and Signaling Pathways;2024

4. ALDH1: A potential therapeutic target for cancer stem cells in solid tumors;Frontiers in Oncology;2022-10-28